MOSCOW, July 24 Clinical trials of a cancer vaccine may begin in the fall of 2025, said Alexander Ginzburg, director of the Gamaleya National Research Center of Epidemiology and Microbiology.
«Now I will say that somewhere in the fall,» Ginzburg told reporters, answering a question about when clinical trials of the cancer vaccine will begin.
Earlier, Ginzburg reported that the cancer vaccine will be personalized, that is, made for each patient individually, and artificial intelligence will help in its development, which will analyze the parameters of the tumor and issue a «blueprint» for the future drug, and specialists will make a vaccine based on it within a week.